Published on June 22, 2017

2 Medtronic’s Infuse Patients To Get $8.45 Million in Settlements

Patients who received Medtronic’s Infuse product to get $8.45 million in settlements

Two patients who were injured by Medtronic’s controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor with financial ties to the company used the product …

Original report

Medtronic Disentangles From Durrani Infuse Lawsuits

Spine patients in Ohio who had back surgery performed by federal fugitive, Atiq Durrani M.D., joined together to sue Medtronic because Durrani used Infuse in an alleged off-label fashion.

Durrani is currently practicing back surgery on Pakistanis after …

Original report

Regents OK $8.5 million for 2 patients suing over financial conflicts

The University of California regents have agreed to pay nearly $8.5 million to settle two lawsuits alleging that a well-known UCLA spine surgeon failed to …

Original report

In letter to Franken, FDA defends handling of Medtronic’s Infuse study

After receiving the FDA’s response to his questions, Franken says the handling of Medtronic’s Infuse study signals a broader need to change how the agency safeguards the public’s health.

He called for “a more robust, proactive medical device …

Original report

Sen. Franken pushes for review of Medtronic Infuse study

Medtronic InFuse Senator Al Franken (D-Minn.) is pushing for more details on Medtronic’s (NYSE:MDT) study of its Infuse Bone Graft, saying that the product …

Original report

Leave a Comment

Your email address will not be published. Required fields are marked *